Development and use of a vaccinia virus neutralization assay based on flow cytometric detection of green fluorescent protein

Journal of Virology

Volumn 77, Issue 19, 2003, Pages 10684-10688

  Earl, Patricia L ^a   Americo, Jeffrey L ^a   Moss, Bernard ^a,b  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GREEN FLUORESCENT PROTEIN; SMALLPOX VACCINE;

ANALYTIC METHOD; ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMALLPOX; VACCINIA VIRUS; VIRUS INFECTION; VIRUS NEUTRALIZATION; VIRUS RECOMBINANT;

ANIMALS; CELL COUNT; FLOW CYTOMETRY; GREEN FLUORESCENT PROTEINS; HELA CELLS; HUMANS; LUMINESCENT PROTEINS; NEUTRALIZATION TESTS; RABBITS; SMALLPOX VACCINE; VACCINATION; VACCINIA VIRUS;

EID: 0141744613     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.77.19.10684-10688.2003     Document Type: Article

References (11)

1. Anton, L. C., U. Schubert, I. Bacik, M. F. Princiotta, P. A. Wearsch, J. Gibbs, P. M. Day, C. Realini, M. C. Rechsteiner, J. R. Bennink, and J. W. Yewdell. 1999. Intracellular localization of proteasomal degradation of a viral antigen. J. Cell Biol. 146:113-124.
2. Carroll, M. W., and B. Moss. 1995. E. coli β-glucuronidase (GUS) as a marker for recombinant vaccinia viruses. BioTechniques 19:352-355.
3. Chakrabarti, S., K. Brechling, and B. Moss. 1985. Vaccinia virus expression vector: coexpression of β-galactosidase provides visual screening of recombinant virus plaques. Mol. Cell. Biol. 5:3403-3409.
4. Dominguez, J., M. D. Lorenzo, and R. Blasco. 1998. Green fluorescent protein expressed by a recombinant vaccinia virus permits early detection of infected cells by flow cytometry. J. Immunol. Methods 220:115-121.
5. Earl, P. L., N. Cooper, S. Wyatt, B. Moss, and M. W. Carroll. 1998. Preparation of cell cultures and vaccinia virus stocks, p. 16.16.1-16.16.3. In F. M. Ausubel, R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl (ed.), Current protocols in molecular biology, vol. 2. John Wiley and Sons, New York, N.Y.
6. Earl, P. L., B. Moss, L. S. Wyatt, and M. W. Carroll. 1998. Generation of recombinant vaccinia viruses, p. 16.17.1-16.17.19. In F. M. Ausubel, R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl (ed.), Current protocols in molecular biology, vol. 2. Greene Publishing Associates & Wiley Interscience, New York, N.Y.
7. Fenner, F., D. A. Henderson, I. Arita, Z. Jezek, and I. D. Ladnyi. 1988. Smallpox and its eradication, 1st ed. World Health Organization, Geneva, Switzerland.
8. Ichihashi, Y., and M. Oie. 1996. Neutralizing epitopes on penetration protein of vaccinia virus. Virology 220:491-494.
9. Mackett, M., G. L. Smith, and B. Moss. 1984. General method for production and selection of infectious vaccinia virus recombinants expressing foreign genes. J. Virol. 49:857-864.
10. Norbury, C. C., D. Malide, J. S. Gibbs, J. R. Bennink, and J. W. Yewdell. 2002. Visualizing priming of virus-specific CD8(+) T cells by infected dendritic cells in vivo. Nat. Immunol. 3:265-271.
11. Whitley, R. J. 2003. Smallpox: a potential agent of bioterrorism. Antivir. Res. 57:7-12.